Neurobiological Technologies, Inc. (NTII)

NTII Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec 17, 2009	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005
Net Income	18.67	3.12	-16.32	-14.13	-27.84	-24.98
Depreciation & Amortization	0.05	0.13	0.21	0.23	0.19	0.07
Other Amortization	-	-	2.34	-	-	-
Loss (Gain) From Sale of Assets	0.03	-	-	-	-	-
Asset Writedown & Restructuring Costs	0.02	0.19	-	-	11.5	12.65
Loss (Gain) From Sale of Investments	0.83	0.86	1.78	-	-	-
Stock-Based Compensation	0.31	0.63	1.01	0.96	0.85	0.03
Other Operating Activities	-0	0.26	-3.38	-0.98	-	-
Change in Accounts Receivable	-0.12	0.42	-0.17	1.14	-1.57	-
Change in Accounts Payable	-7.36	-3.25	-1.24	1.2	0.29	3.16
Change in Unearned Revenue	-16.04	-18.79	-5.5	-5.5	29.79	-
Change in Other Net Operating Assets	-0.13	0.01	0.58	3.96	-4.24	-0.33
Operating Cash Flow	-3.69	-16.43	-20.7	-13.13	8.98	-9.4
Capital Expenditures	-	-0	-0.01	-0.07	-0.35	-0.65
Cash Acquisitions	-	-	-	-	-2	-2.95
Investment in Securities	24.97	-3.28	-11.75	2.13	2.17	11.11
Investing Cash Flow	24.97	-3.28	-11.76	2.07	-0.18	7.52
Short-Term Debt Repaid	-	-	-6	-	-	-
Total Debt Repaid	-	-	-6	-	-	-
Net Debt Issued (Repaid)	-	-	-6	-	-	-
Issuance of Common Stock	0.06	0	60.86	6.86	0.11	0.7
Financing Cash Flow	-25.32	0	54.86	6.86	0.11	0.7
Net Cash Flow	-4.04	-19.71	22.4	-4.2	8.91	-1.18
Free Cash Flow	-3.69	-16.43	-20.71	-13.2	8.63	-10.05
Free Cash Flow Margin	-14.58%	-62.36%	-140.30%	-74.67%	69.92%	-324.24%
Free Cash Flow Per Share	-0.14	-0.61	-1.06	-3.04	2.12	-2.65
Cash Interest Paid	-	-	0.14	-	-	-
Cash Income Tax Paid	-	-	-	0.28	0.13	-
Levered Free Cash Flow	-	-4.48	-13.22	1.11	-9.6	-5.48
Unlevered Free Cash Flow	-	-4.48	-14	1.11	-9.6	-5.48
Change in Working Capital	-23.59	-21.62	-6.32	0.79	24.27	2.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.